The latest healthcare and wellness news from Asia and the Pacific

Provided by AGP

Got News to Share?

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on April 2, 2026

Traditional Medicine Market Expected to Witness Rapid Expansion Through 2033 | Tasly Holding Group Co., Ltd
Foot Creams and Lotions Market is Booming with Strong Growth Prospects |  PediFix Inc., Alba Botanica
Industrial Hose Market Set to Witness Rapid Growth Through 2033 | Coherent Market Insights
ATHANASIOU OLIVE OIL Co. SWEEPS TOP HONORS: MICRO-PRODUCER WINS BIG at the 2026 LOS ANGELES INT'L OLIVE OIL COMPETITION
Pipper Standard® 以爆发式增长重塑亚洲宠物经济: 从“宠物友好”迈向“宠物健康”
Pipper Standard® Redefines Asia’s Pet Economy with Explosive Growth in Hong Kong
MESA LABS DECLARES QUARTERLY DIVIDEND
Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026
Conavi Medical Announces Results from Its Annual General Meeting of Shareholders
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2026
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions
Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:

Sign up for:

Asia Healthcare Industry Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.